$52.95
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
+29.53%
6M
+8.73%
1Y
-30.96%
YTD
+12.25%
Open$52.95
Previous Close$52.95
Day High$52.96
Day Low$52.93
52W High$90.32
52W Low$29.43
Volume—
Avg Volume1.79M
Market Cap2.76B
P/E Ratio132.11
EPS$0.16
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$44.35
Above
SMA 200
$63.31
Below
RSI (14)
47.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-62.3% upside
Current
$52.95
$52.95
Target
$19.95
$19.95
$16.99
$19.95 avg
$27.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 189.44M | 785.64M | 787.82M |
| Net Income | 20.79M | 73.80M | 76.85M |
| Profit Margin | 11.0% | 9.4% | 9.8% |
| EBITDA | 11.37M | 123.66M | 121.59M |
| Free Cash Flow | — | 65.88M | 73.67M |
| Rev Growth | +298.9% | +24.2% | +9.0% |
| Debt/Equity | 0.11 | 0.21 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |